⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 1, 2026Mental Health ClinicianOpen Access

Treatment of disruptive mood dysregulation disorder with autism spectrum disorder and attention-deficit/hyperactivity disorder

Sandra Mitchell

View Full Paper

Ask AI

Bookmark

Share

Key Points

Symptom management improved for children diagnosed with disruptive mood dysregulation disorder.
Key evidence includes a 40% reduction in behavioral episodes over six months of intervention.
Assessment using intervention strategies for behavioral therapy and medication showed effectiveness.
Supports the need for tailored treatments addressing complex mood disorders in autism and ADHD.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Observational analysis demonstrates symptom management in children with autism and ADHD, highlighting intervention importance.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sandra Mitchell (2026) studied this question.

synapsesocial.com/papers/69a7609bc6e9836116a2d842 https://doi.org/10.9740/mhc.2026.02.001

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Lithium toxicity following a change from semaglutide to tirzepatide for weight loss managementMental Health Clinician · 2026
2Protracted escitalopram discontinuation syndrome and serotonin toxicity associated with CYP2C19 poor metabolism: A case reportMental Health Clinician · 2026
3Pharmacists expand access to contingency management in patients with substance use disordersMental Health Clinician · 2026
4Perceived barriers to and values of PGY2 psychiatric pharmacy resident research project publicationMental Health Clinician · 2026
5Examining individual serotonin and norepinephrine reuptake inhibitors and fall-related hospitalizations in older adultsMental Health Clinician · 2026

Inpatient prescribing trends and differences in drug acquisition costs of long-acting injectable subcutaneous risperidone versus paliperidone palmitate: A single-center medication use evaluationMental Health Clinician · 2026
Clinical benefits and considerations of dextromethorphan and bupropion administered separately for managing depression: A case reportMental Health Clinician · 2026
Safety considerations for patients using cannabisMental Health Clinician · 2025
The efficacy and safety of antidepressants as alternative treatment of attention-deficit/hyperactivity disorder in pediatric populationsMental Health Clinician · 2025
Rational antipsychotic polypharmacy in psychotic and bipolar disorders: A focus on D2 receptor partial agonistsMental Health Clinician · 2025

More from Mental Health Clinician

More from Virginia Commonwealth University